Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

recombinant vaccinia prostate-specific antigen vaccine

A vaccine consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA). Vaccination with recombinant vaccinia prostate-specific antigen vaccine stimulates the host immune system to mount a cytotoxic T-cell response against tumor cells expressing PSA.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	Prostate Specific Antigen Expressing Vaccinia Virus Vaccine rV-PSA RV-PSA (RECOMB VACCINIA/PSA-CV-1) rV-PSA vaccine vaccinia prostate-specific antigen vaccine Vaccinia PSA Vaccine vaccinia-prostate-specific antigen vaccine Vaccinia-PSA Vaccine
Abbreviation:	VPSA
IND number:	6698 7718 8202
NSC code:	678892 697729

recombinant vaccinia prostate-specific antigen vaccine

Search NCI's Drug Dictionary